Skip to main content
. 2015 Dec 14;112(52):E7230–E7238. doi: 10.1073/pnas.1507459112

Fig. S5.

Fig. S5.

Low dose treatment with NF-κB and JNK inhibitors. B cells from CARD11(L225LI)CD19-Cre mice were treated with solvent control (−) or 1 μM Bay11-7082 (A) or 1 μM SP600125 (B) (+) for 4 h, and nuclear lysates were examined for the presence of NF-κB p50 (A) and phospho-c-Jun (B) using Western blotting. Representative results from three experiments are shown.